Cite
Novel scorpion venom peptide HsTx2 ameliorates cerebral ischemic brain injury in rats via the MAPK signaling pathway.
MLA
Tao, Jian, et al. “Novel Scorpion Venom Peptide HsTx2 Ameliorates Cerebral Ischemic Brain Injury in Rats via the MAPK Signaling Pathway.” Biochemical & Biophysical Research Communications, vol. 534, Jan. 2021, pp. 442–49. EBSCOhost, https://doi.org/10.1016/j.bbrc.2020.11.062.
APA
Tao, J., Yin, S., Song, Y., Zeng, L., Li, S., Liu, N., Sun, H., Fu, Z., Wang, Y., Li, Y., Liu, Y., Sun, J., Wang, Y., & Yang, X. (2021). Novel scorpion venom peptide HsTx2 ameliorates cerebral ischemic brain injury in rats via the MAPK signaling pathway. Biochemical & Biophysical Research Communications, 534, 442–449. https://doi.org/10.1016/j.bbrc.2020.11.062
Chicago
Tao, Jian, Saige Yin, Yongli Song, Lin Zeng, Shanshan Li, Naixin Liu, Huiling Sun, et al. 2021. “Novel Scorpion Venom Peptide HsTx2 Ameliorates Cerebral Ischemic Brain Injury in Rats via the MAPK Signaling Pathway.” Biochemical & Biophysical Research Communications 534 (January): 442–49. doi:10.1016/j.bbrc.2020.11.062.